7th Annual Global Summit on Genitourinary Malignancies

7th Annual Global Summit on Genitourinary Malignancies is organized by DAVA oncology and will be held from Nov 20 - 24, 2024 at The Broadmoor, Colorado Springs, Colorado, United States of America.

Description:
The management of genitourinary malignancies has undergone significant advancements in recent years. Renal cell carcinoma, urothelial carcinoma of the bladder, and prostate adenocarcinoma are among the most prevalent genitourinary cancers, characterized by diverse histological profiles and treatment approaches. However, all three types have experienced substantial shifts in their therapeutic landscapes, driven by a deeper comprehension of their molecular mechanisms and oncogenic drivers.

One of the most notable breakthroughs in recent times has been the emergence of immunotherapies, particularly immune checkpoint inhibitors. In addition to immunotherapy, researchers are actively exploring innovative agents targeting various molecular targets, including antibody drug conjugates, PARP inhibitors, small-molecule tyrosine kinase inhibitors, mTOR inhibitors, and novel fusion proteins, among others.